Skip to main content
Erschienen in: Cancer Causes & Control 9/2007

01.11.2007 | Original Paper

Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography

verfasst von: Todd A. MacKenzie, Linda Titus-Ernstoff, Pamela M. Vacek, Berta Geller, Julia E. Weiss, Martha E. Goodrich, Patricia A. Carney

Erschienen in: Cancer Causes & Control | Ausgabe 9/2007

Einloggen, um Zugang zu erhalten

Abstract

Objective

To examine the association between breast density and risk of breast ductal carcinoma in situ (DCIS).

Methods

We assessed breast density in relation to DCIS risk using combined data from statewide mammography registries in NH and VT. The prospective analyses were based on 572 DCIS cases arising in 154,936 women (58,496 premenopausal and 96,440 postmenopausal). Women in the study were followed on average 4.1 years. Breast density was scored by community radiologists using BIRADS categories (fatty, scattered density, heterogeneous density, extreme density).

Results

In premenopausal women, based on 157 cases, the RR for DCIS risk were 0.29 (95% CI: 0.0.04, 2.24) for fatty breasts, 2.06 (95% CI: 1.39, 3.05) for heterogeneous density, and 2.40 (95% CI: 1.47, 3.91) for extreme density, relative to scattered density. In postmenopausal women, based on 369 cases, the RR for DCIS risk were 0.58 (95% CI: 0.37, 0.93) for fatty breasts, 1.41 (95% CI: 1.12, 1.78) for heterogeneous density, and 1.49 (95% CI: 0.93, 2.37) for extreme density, relative to scattered density. The possible interaction between breast density and menopausal status in relation to DCIS risk was not statistically significant.

Conclusions

We observed an association between breast density and DCIS risk. Although the association seemed stronger in premenopausal women, there was no evidence of an interaction involving breast density and menopausal status.
Literatur
1.
Zurück zum Zitat Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554PubMed Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554PubMed
2.
Zurück zum Zitat Habel LA, Dignan JJ, Land SR, Salane M, Capra AM, Julian TB (2004) Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst 96:1467–1472PubMedCrossRef Habel LA, Dignan JJ, Land SR, Salane M, Capra AM, Julian TB (2004) Mammographic density and breast cancer after ductal carcinoma in situ. J Natl Cancer Inst 96:1467–1472PubMedCrossRef
3.
Zurück zum Zitat Boyages J, Delaney G, Taylor R (1999) Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85:616–628PubMedCrossRef Boyages J, Delaney G, Taylor R (1999) Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer 85:616–628PubMedCrossRef
4.
Zurück zum Zitat Warnberg F, Yuen J, Holmberg L (2000) Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet 355:724–725PubMedCrossRef Warnberg F, Yuen J, Holmberg L (2000) Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet 355:724–725PubMedCrossRef
5.
Zurück zum Zitat Leonard GD, Swain SM (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96:906–920PubMedCrossRef Leonard GD, Swain SM (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96:906–920PubMedCrossRef
6.
Zurück zum Zitat Baxter NN, Virnig BA, Durham SB, Tuttle TM (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443–448PubMedCrossRef Baxter NN, Virnig BA, Durham SB, Tuttle TM (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443–448PubMedCrossRef
7.
Zurück zum Zitat Sewell CW (2004) Pathology of high-risk breast lesions and ductal carcinoma in situ. Radiol Clin North Am 42:821–30, v Sewell CW (2004) Pathology of high-risk breast lesions and ductal carcinoma in situ. Radiol Clin North Am 42:821–30, v
8.
Zurück zum Zitat Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE (2004) Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology 36:221–229PubMedCrossRef Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE (2004) Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology 36:221–229PubMedCrossRef
9.
Zurück zum Zitat Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould W (2004) Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol 122:217–221PubMedCrossRef Renshaw AA, Derhagopian RP, Tizol-Blanco DM, Gould W (2004) Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol 122:217–221PubMedCrossRef
10.
11.
Zurück zum Zitat Ali-Fehmi R, Carolin K, Wallis T, Visscher DW (2003) Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 34:234–239PubMedCrossRef Ali-Fehmi R, Carolin K, Wallis T, Visscher DW (2003) Clinicopathologic analysis of breast lesions associated with multiple papillomas. Hum Pathol 34:234–239PubMedCrossRef
12.
Zurück zum Zitat Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG (2003) Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer 97:1393–1403PubMedCrossRef Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG (2003) Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer 97:1393–1403PubMedCrossRef
13.
Zurück zum Zitat Wohlfahrt J, Rank F, Kroman N, Melbye M (2004) A comparison of reproductive risk factors for CIS lesions and invasive breast cancer. Int J Cancer 108:750–753PubMedCrossRef Wohlfahrt J, Rank F, Kroman N, Melbye M (2004) A comparison of reproductive risk factors for CIS lesions and invasive breast cancer. Int J Cancer 108:750–753PubMedCrossRef
14.
Zurück zum Zitat Claus EB, Stowe M, Carter D (2003) Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res Treat 81:129–136PubMedCrossRef Claus EB, Stowe M, Carter D (2003) Oral contraceptives and the risk of ductal breast carcinoma in situ. Breast Cancer Res Treat 81:129–136PubMedCrossRef
15.
Zurück zum Zitat Claus EB, Stowe M, Carter D (2001) Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93:1811–1817PubMedCrossRef Claus EB, Stowe M, Carter D (2001) Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93:1811–1817PubMedCrossRef
16.
Zurück zum Zitat Patel AV, Press MF, Meeske K, Calle EE, Bernstein L (2003) Lifetime recreational exercise activity and risk of breast carcinoma in situ. Cancer 98:2161–2169PubMedCrossRef Patel AV, Press MF, Meeske K, Calle EE, Bernstein L (2003) Lifetime recreational exercise activity and risk of breast carcinoma in situ. Cancer 98:2161–2169PubMedCrossRef
17.
Zurück zum Zitat Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V (1997) Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89:76–82PubMed Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V (1997) Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89:76–82PubMed
18.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Storer BE (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9:697–703PubMed Trentham-Dietz A, Newcomb PA, Storer BE (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9:697–703PubMed
19.
Zurück zum Zitat Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami HO (1998) Parity, age at first birth and the risk of carcinoma in situ of the breast. Int J Cancer 77:330–332PubMedCrossRef Lambe M, Hsieh CC, Tsaih SW, Ekbom A, Trichopoulos D, Adami HO (1998) Parity, age at first birth and the risk of carcinoma in situ of the breast. Int J Cancer 77:330–332PubMedCrossRef
20.
Zurück zum Zitat Weiss HA, Brinton LA, Brogan D et al (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Brit J Cancer 73:1298–1305PubMed Weiss HA, Brinton LA, Brogan D et al (1996) Epidemiology of in situ and invasive breast cancer in women aged under 45. Brit J Cancer 73:1298–1305PubMed
21.
Zurück zum Zitat Gapstur SM, Morrow M, Sellers TA (1999) Hormone replacement therapy and risk of breast cancer with a favorable histology. J Am Med Assoc 281:2091–2097CrossRef Gapstur SM, Morrow M, Sellers TA (1999) Hormone replacement therapy and risk of breast cancer with a favorable histology. J Am Med Assoc 281:2091–2097CrossRef
22.
Zurück zum Zitat Brisson J, Morrison AS, Kopans DB et al (1984) Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 119:371–381PubMed Brisson J, Morrison AS, Kopans DB et al (1984) Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 119:371–381PubMed
23.
Zurück zum Zitat Byrne C, Schairer C, Wolf J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629PubMedCrossRef Byrne C, Schairer C, Wolf J et al (1995) Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 87:1622–1629PubMedCrossRef
24.
Zurück zum Zitat Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144PubMed Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:1133–1144PubMed
25.
Zurück zum Zitat Gill JK, Maskarinec G, Pagano I, Kolonel LN (2006) The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 8:R30PubMedCrossRef Gill JK, Maskarinec G, Pagano I, Kolonel LN (2006) The association of mammographic density with ductal carcinoma in situ of the breast: the Multiethnic Cohort. Breast Cancer Res 8:R30PubMedCrossRef
26.
Zurück zum Zitat Boyd NF, Jensen HM, Cooke G, Lee Han H (1992) Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst 84:1170–1179PubMedCrossRef Boyd NF, Jensen HM, Cooke G, Lee Han H (1992) Relationship between mammographic and histological risk factors for breast cancer. J Natl Cancer Inst 84:1170–1179PubMedCrossRef
27.
Zurück zum Zitat American College of Radiology (ACR) (2003) Breast imaging reporting and data system atlas (BI-RADS® Atlas), © American College of Radiology, Reston, Va American College of Radiology (ACR) (2003) Breast imaging reporting and data system atlas (BI-RADS® Atlas), © American College of Radiology, Reston, Va
28.
Zurück zum Zitat Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230:29–41PubMedCrossRef Harvey JA, Bovbjerg VE (2004) Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 230:29–41PubMedCrossRef
29.
Zurück zum Zitat Warner E, Lockwood G, Tritchler D, Boyd NF (1992) The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 16:67–72PubMed Warner E, Lockwood G, Tritchler D, Boyd NF (1992) The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev 16:67–72PubMed
30.
Zurück zum Zitat De Stavola BL, Gravelle IH, Wang DY et al (1990) Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol 19:247–254PubMedCrossRef De Stavola BL, Gravelle IH, Wang DY et al (1990) Relationship of mammographic parenchymal patterns with breast cancer risk factors and risk of breast cancer in a prospective study. Int J Epidemiol 19:247–254PubMedCrossRef
31.
Zurück zum Zitat Baines CJ, Dayan R (1999) A tangled web: factors likely to affect the efficacy of screening mammography. J Natl Cancer Inst 91:833–838PubMedCrossRef Baines CJ, Dayan R (1999) A tangled web: factors likely to affect the efficacy of screening mammography. J Natl Cancer Inst 91:833–838PubMedCrossRef
32.
Zurück zum Zitat Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9:151–160PubMed Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9:151–160PubMed
33.
Zurück zum Zitat Gram IT, Funkhouser E, Tabar L (1999) Moderate physical activity in relation to mammographic patterns. Cancer Epidemiol Biomarkers Prev 8:117–122PubMed Gram IT, Funkhouser E, Tabar L (1999) Moderate physical activity in relation to mammographic patterns. Cancer Epidemiol Biomarkers Prev 8:117–122PubMed
34.
Zurück zum Zitat Chen Z, Wu AH, Gauderman J et al (2004) Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 159:140–147PubMedCrossRef Chen Z, Wu AH, Gauderman J et al (2004) Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol 159:140–147PubMedCrossRef
35.
Zurück zum Zitat Nagata C, Matsubara T, Fujita H et al (2005) Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer 92:2102–2106PubMedCrossRef Nagata C, Matsubara T, Fujita H et al (2005) Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer 92:2102–2106PubMedCrossRef
36.
Zurück zum Zitat Maskarinec G, Meng L (2000) A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat 63:153–161PubMedCrossRef Maskarinec G, Meng L (2000) A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat 63:153–161PubMedCrossRef
37.
Zurück zum Zitat Rutter CM, Mandelson MT, Laya MB, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. J Am Med Assoc 285:171–176CrossRef Rutter CM, Mandelson MT, Laya MB, Taplin S (2001) Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. J Am Med Assoc 285:171–176CrossRef
38.
Zurück zum Zitat Titus-Ernstoff L, Tosteson A, Kasales C et al (2006) Breast cancer risk factors in relation to breast density. Cancer Causes Control 17:1281–1290PubMedCrossRef Titus-Ernstoff L, Tosteson A, Kasales C et al (2006) Breast cancer risk factors in relation to breast density. Cancer Causes Control 17:1281–1290PubMedCrossRef
39.
Zurück zum Zitat Chow CK, Venzon D, Jones EC, Premkumar A, O’Shaughnessy J, Zujewski J (2000) Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9:917–921PubMed Chow CK, Venzon D, Jones EC, Premkumar A, O’Shaughnessy J, Zujewski J (2000) Effect of tamoxifen on mammographic density. Cancer Epidemiol Biomarkers Prev 9:917–921PubMed
40.
Zurück zum Zitat Boyd NF, Dite GS, Stone J et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886–894PubMedCrossRef Boyd NF, Dite GS, Stone J et al (2002) Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 347(12):886–894PubMedCrossRef
41.
Zurück zum Zitat Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH (2005) Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 7:R605–R608PubMedCrossRef Ursin G, Hovanessian-Larsen L, Parisky YR, Pike MC, Wu AH (2005) Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res 7:R605–R608PubMedCrossRef
42.
Zurück zum Zitat Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF (1992) Case-control study of factors associated with failure to detect breast cancer by mammography. J Nat Cancer Inst 84:781–785PubMedCrossRef Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF (1992) Case-control study of factors associated with failure to detect breast cancer by mammography. J Nat Cancer Inst 84:781–785PubMedCrossRef
43.
Zurück zum Zitat Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen detected cancers. Jour Nat Cancer Inst 92:1081–1087CrossRef Mandelson MT, Oestreicher N, Porter PL et al (2000) Breast density as a predictor of mammographic detection: comparison of interval- and screen detected cancers. Jour Nat Cancer Inst 92:1081–1087CrossRef
44.
45.
Zurück zum Zitat Holland R, Hendriks JH, Mravunac M (1983) Mammographically occult breast cancer. A pathologic and radiologic study. Cancer 52:1810–1819PubMedCrossRef Holland R, Hendriks JH, Mravunac M (1983) Mammographically occult breast cancer. A pathologic and radiologic study. Cancer 52:1810–1819PubMedCrossRef
46.
Zurück zum Zitat Boyd NH, Rommens JM, Vogt K et al (2005) Mammographic density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798–808PubMedCrossRef Boyd NH, Rommens JM, Vogt K et al (2005) Mammographic density as an intermediate phenotype for breast cancer. Lancet Oncol 6:798–808PubMedCrossRef
Metadaten
Titel
Breast density in relation to risk of ductal carcinoma in situ of the breast in women undergoing screening mammography
verfasst von
Todd A. MacKenzie
Linda Titus-Ernstoff
Pamela M. Vacek
Berta Geller
Julia E. Weiss
Martha E. Goodrich
Patricia A. Carney
Publikationsdatum
01.11.2007
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 9/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-007-9035-3

Weitere Artikel der Ausgabe 9/2007

Cancer Causes & Control 9/2007 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.